GRANT. Two projects at WCMTM receive funding from the Swedish Research Council for clinical therapy research. The studies receiving support should have a clear connection to the needs of healthcare and demonstrate patient and societal benefits within five years after the end of the projects. Anders Rosengren receives nearly SEK 19 million during the period 2024-2027 for his research on type 2 diabetes and the evaluation of long-term preventive measures…
VR funds national postgraduate school in compulsory psychiatric care and forensic psychiatry
POSTGRADUATE STUDIES. A new national postgraduate school in compulsory psychiatric care and forensic psychiatry is now being established by the University of Gothenburg in cooperation with Lund University. The graduate school is funded with SEK 30 million from the Swedish Research Council. The primary applicant for the funding of the new postgraduate school is Peter Andiné, professor of forensic psychiatry at the University of Gothenburg and senior physician at Sahlgrenska…
Total of over 150 million SEK from the Swedish Research Council
GRANTS. A total of 44 researchers receive research funding as the Swedish Research Council has now announced its decisions in both medicine and health, as well as research competence in primary care. Over 150 million SEK is allocated to various projects. The largest grants go to Maria Åberg and Hanna Hebelka Bolminger, each receiving 7.4 million SEK. Here you can see the list of all researchers receiving grants from the…
“The ALF evaluation is a great achievement for the researchers”
CLINICAL RESEARCH. Our researchers deserve credit for the excellent results of the ALF evaluation. The excellent conditions for clinical research created jointly by Region Västra Götaland and the University of Gothenburg have also contributed greatly to the outcome. That is the message from Pro-Dean Henrik Hagberg. Results of the ALF (Agreement for Cooperation on Medical Education and Research) evaluation at the end of March clearly indicated that ALF region Västra…
Testing a immunological drug as a new treatment for early type 1 diabetes
CLINICAL STUDY. A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1 diabetes. The theory is that the drug could preserve the patient’s remaining insulin production. A large number of hospitals throughout Sweden are participating in this large project, which is funded by the Swedish Research Council within clinical treatment research. The…